MDT Earnings Prediction
The chart below shows how MDT performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MDT sees a +0.18% change in stock price 10 days leading up to the earnings, and a -1.26% change 10 days following the report. On the earnings day itself, the stock moves by -1.34%. This data can give you a slight idea of what to expect for the next quarter's release.
MDT Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
8.40B
5.25%
6.17%
Gross Margin
60.16%
-0.20%
0.27%
Operating Margin
19.39%
-2.27%
6.13%
Net Margin
15.21%
33.30%
14.79%
EPS
0.99
45.59%
23.75%
No Data Available
MDT Earnings Analysis
Medtronic plc Corporation (MDT.N) Earnings Conference Call
Positive
Strong Revenue Performance: The company delivered strong top-line performance with revenue growth of 5%, 50 basis points above our guidance.
Adjusted EPS Performance: Adjusted EPS was $1.26, $0.01 above the midpoint of our guidance.
Investment and Bottom Line Growth: We continue to invest in our pipeline and behind our emerging growth drivers while also delivering bottom line growth, which was up 8% on a constant currency basis.
Organic Revenue Growth Forecast: We expect fiscal '25 organic revenue growth of 4.75% to 5%, an increase from the prior range of 4.5% to 5%.
EPS Guidance Increase: We are raising our fiscal '25 non-GAAP diluted EPS guidance to a new range of $5.44 to $5.50, an increase from the prior range of $5.42 to $5.50.
Negative
CAS Growth Decline: The company experienced a decline in overall CAS growth, which did not accelerate as expected this quarter due to a third-party component supplier interruption.
Gross Margin Decline Analysis: The adjusted gross margin was 65.2%, down 70 basis points, indicating a decline driven entirely by foreign currency effects.
Foreign Currency Impact Estimate: The company expects a negative impact from foreign currency in fiscal '25, estimated between $225 million to $325 million, including $100 million to $150 million in the third quarter.
CAS Growth Challenges: The overall CAS growth did not accelerate as expected this quarter due to a third-party component supplier interruption, which has now been resolved but affected performance.
Flat Gross Margin Outlook: The company anticipates a flat gross margin on a constant currency basis for fiscal '25, indicating challenges in maintaining profitability.
MDT FAQs
How does MDT typically perform around its earnings report dates?
Is Medtronic plc (MDT) Q2 2025 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MDT Earning Call Sentiment
Medtronic plc (MDT) Q2 2025 Earnings Call Transcript
1.0x
00:00
00:00
MDT.N
2.52%Positive
The earnings call reveals strong financial performance, with revenue and EPS growth exceeding expectations despite foreign currency impacts. The partnership with Abbott is a positive catalyst, and guidance has been raised, indicating confidence in future growth. While there are some uncertainties in market adoption and foreign currency effects, the commitment to shareholder returns through dividends and share repurchases, along with operational improvements, provide a positive outlook. The Q&A section reinforces management's focus on growth and overcoming challenges, supporting a positive sentiment for the stock over the next two weeks.